본문 바로가기

The Effects of Thoracic Epidural Analgesia during Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q2
저널
PAIN RESEARCH & MANAGEMENT2018 · 2018
피인용
Web of Science 10Scopus 12
FWCI (Scopus)
0.39
JCR IF
JCR 2017 1.27
ISSN
1203-6765

저자

  1. 최은지제1저자Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  2. 최윤미Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  3. 김혜진Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  4. 옥회경Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  5. 장은정Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  6. 김희영Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  7. 윤지욱Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  8. 김경훈Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea
  9. 변경조교신저자Department of Anesthesia and Pain Medicine, Pusan National University, Yangsan Hospital, Pusan National University School of Medicine, Busan, South Korea

초록

Background. Percutaneous radiofrequency ablation (PRFA) is a useful and safe treatment for hepatocellular carcinoma (HCC). Pain management, during and after PRFA, is a critical component of patient care. Objectives. This study reviewed the efficacy of thoracic epidural analgesia, during and after PRFA, for patients with HCC. Study Design. A retrospective, observational chart review. Setting. Tertiary medical center/teaching hospital. Methods. Patients who had undergone PRFA for HCC in the past 5 years were divided into two groups, based on the type of anesthesia administered: thoracic epidural anesthesia group (Group E) and local anesthesia with monitored anesthesia care group (Group C). We retrospectively reviewed changes in the numeric rating scale (NRS) score during and after PRFA, opioid consumption, length of the procedure, length of hospital stay, changes in blood pressure during PRFA, and the incidence of adverse events. Results. The NRS score in Group E was significantly lower than that in Group C (P < 0.05). The opioid consumption in Group E was lower than that in Group C after PRFA (P < 0.05). The procedure time was shorter in Group E (P < 0.05). Neither of the groups showed significant difference with respect to the length of hospital stay and the incidence of respiratory depression, fever, and blood pressure elevation. The incidence of nausea, vomiting, and voiding difficulty was higher in Group E. Limitations. This study is limited by its retrospective design. Conclusions. Thoracic epidural analgesia was associated with shorter procedure times, lower postprocedural pain, and lower opioid consumption during and after PRFA for HCC.

키워드

PARAVERTEBRAL ANESTHESIAHEPATIC RESECTIONCOMPLICATIONSMANAGEMENTDIAGNOSISCANCER

식별자

Scopus EID
2-s2.0-85058324473
WoS UID
000451884300001